Skip to main content
. Author manuscript; available in PMC: 2016 Aug 10.
Published in final edited form as: Nat Rev Clin Oncol. 2015 Sep 22;13(2):92–105. doi: 10.1038/nrclinonc.2015.152

Figure 1. Posterior Reversible Encephalopathy Syndrome.

Figure 1

The patient is a 68-year-old woman with stage IV serous ovarian carcinoma treated with bevacizumab from 4/2012-9/2012. In 9/2012, she developed hypertension and mental status changes.

A. MRI Brain FLAIR sequence from 10/9/2012 shows confluent hyperintensities within the supratentorial white matter, predominantly within the posterior temporal and occipital lobes consistent with PRES.

B. MRI Brain FLAIR sequence from 4/4/2013 shows resolution of extensive white matter changes after discontinuation of bevacizumab treatment.